• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Brookdale Senior Living Inc.

    4/14/25 6:49:09 AM ET
    $BKD
    Hospital/Nursing Management
    Health Care
    Get the next $BKD alert in real time by email
    DEFA14A 1 april13th8k.htm DEFA14A Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    FORM8-K
     
    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
     
     
    Date of Report (Date of earliest event reported)April 13, 2025
    Brookdale Senior Living Inc.
    (Exact name of registrant as specified in its charter)
    Delaware001-3264120-3068069
    (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
    105 Westwood Place,Suite 400,Brentwood,Tennessee37027
    (Address of principal executive offices)(Zip Code)
    Registrant's telephone number, including area code (615)221-2250
     
    (Former name or former address, if changed since last report.)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
      
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
      
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
      
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, $0.01 Par Value Per ShareBKDNew York Stock Exchange
    7.00% Tangible Equity UnitsBKDTNew York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 2.02    Results of Operations and Financial Condition.

    On April 14, 2025, Brookdale Senior Living Inc. (the "Company") issued a press release announcing that, based on the Company’s preliminary results, its Adjusted EBITDA for the first quarter ended March 31, 2025 is expected to exceed both the Company’s and analyst consensus expectations, the Company expects to report positive Adjusted Free Cash Flow for the quarter, and RevPAR is expected to exceed the Company’s expectations. A copy of the press release is furnished herewith as Exhibit 99.1, which includes definitions of Adjusted EBITDA, Adjusted Free Cash Flow, and RevPAR.

    The information furnished pursuant to this Item 2.02 (including the exhibit hereto) shall not be considered "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into any filing by the Company under the Securities Act of 1933, as amended, or under the Securities Exchange Act of 1934, as amended, unless the Company expressly sets forth by specific reference in such filing that such information is to be considered "filed" or incorporated by reference therein.

    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    Departure of President, Chief Executive Officer and Board Member

    On April 14, 2025, the Company announced that the board of directors of the Company (the “Board”) and Lucinda M. Baier, the Company’s President and Chief Executive Officer and member of the Board, mutually agreed that Ms. Baier’s role serving as the Company’s President and Chief Executive Officer and as a member of the Board would cease, effective as of April 13, 2025. Ms. Baier’s departure is not related to any disagreement between her and the Company or the Board. In connection with Ms. Baier’s departure, the Company and Ms. Baier entered into a Separation Agreement on April 13, 2025 (the “Separation Agreement”). Pursuant to the Separation Agreement, Ms. Baier will receive the severance payments and benefits, including certain equity award acceleration and continued vesting, that she is entitled to receive pursuant to her previously disclosed Amended and Restated Employment Agreement, dated November 3, 2021, and certain outplacement services, subject to the terms and conditions set forth in the Separation Agreement.

    Appointment of Interim Chief Executive Officer

    In connection with Ms. Baier’s departure, on April 13, 2025, the Board appointed Denise W. Warren, current Chairman of the Board, as Interim Chief Executive Officer, to serve until the appointment of a new Chief Executive Officer of the Company. The Board initiated a search for the Company’s next Chief Executive Officer. The search is being led by a committee made up of the Chairman of the Board and three independent directors of the Board with the support of a nationally recognized executive search firm.

    Ms. Warren brings more than 30 years of operational, financial and healthcare experience. Most recently, she served as Executive Vice President and Chief Operating Officer of WakeMed Health & Hospitals from October 2015 through December 2020, where she was responsible for the strategic, financial, and operational performance of the organization’s network of facilities in the North Carolina Research Triangle area. Prior to that, from 2005 to September 2015, Ms. Warren served as Chief Financial Officer of Capella Healthcare, Inc., an owner and operator of general acute-care hospitals, as well as its Executive Vice President since January 2014, and as its Senior Vice President prior to that. Before joining Capella, she served as Senior Vice President and Chief Financial Officer of Gaylord Entertainment Company from 2000 to 2001, as Senior Equity Analyst and Research Director for Avondale Partners LLC and as Senior Equity Analyst for Merrill Lynch & Co. Until November 2024, she served on the Board of Directors of TruBridge, Inc. (formerly known as Computer Programs and Systems, Inc.), where she served as Chair of the Audit Committee and the Compensation Committee. She currently serves on the Board of Directors of Newport Healthcare, Straive, and Virtusa, Inc. Ms. Warren is National Association of Corporate Directors (NACD) Directorship CertifiedTM and received a Corporate Directors Certificate from Harvard Business School. Ms. Warren earned a B.S. degree in Economics from Southern Methodist University and an M.B.A. from Harvard University.

    There are no family relationships, as defined in Item 401 of Regulation S-K, between Ms. Warren and any of the Company’s executive officers or directors or persons nominated or chosen to become a director or executive officer. Ms. Warren has not engaged in any transaction with the Company during the last fiscal year, and does not propose to engage in any transaction, that would be reportable under Item 404(a) of Regulation S-K. There is no arrangement or understanding between Ms. Warren and any other person pursuant to which she was appointed to serve as Interim Chief Executive Officer.




    Interim Office of the CEO

    In connection with Ms. Baier’s departure, on April 13, 2025, the Board also established an Interim Office of the Chief Executive Officer (the “Office of the CEO”) and delegated the powers and duties of the Chief Executive Officer of the Company to the Interim CEO and the Office of the CEO. The Board appointed Ms. Warren, Dawn L. Kussow, Executive Vice President and Chief Financial Officer of the Company, and Chad C. White, Executive Vice President, General Counsel and Secretary of the Company, to serve as members of the Office of the CEO (and designated each of Ms. Warren, Ms. Kussow and Mr. White as a principal executive officer of the Company), in each case, effective as of April 13, 2025. Each of Ms. Kussow and Mr. White will remain in their current positions with the Company while carrying out their Office of the CEO responsibilities. The Office of the CEO will dissolve upon the appointment of a new Chief Executive Officer of the Company.

    Ms. Kussow joined the Company in March 2007 and has served as the Company’s Executive Vice President and Chief Financial Officer since February 2023. She also served as the Company’s Interim Chief Financial Officer from August 2022 to October 2022. Ms. Kussow previously served as Senior Vice President and Chief Accounting Officer from January 2016 until January 2023, Vice President and Corporate Controller from February 2014 to January 2016, Senior Director of Financial Reporting from June 2009 until January 2014, and Director of Financial Reporting from March 2007 until May 2009. Ms. Kussow is a Certified Public Accountant. Before joining the Company, Ms. Kussow served as Director of Financial Reporting for AON Hewitt from 2005 until 2007 and practiced nine years at Deloitte & Touche, LLP, including an international assignment. She received a B.S. in Accounting from Marquette University. Ms. Kussow also serves as a member of the Finance Committee for the Betty Brinn Children’s Museum.

    Mr. White joined the Company in February 2007 and has served as the Company’s Executive Vice President since January 2018, General Counsel since March 2017 and Secretary since March 2013. He previously served as the Company’s Senior Vice President and General Counsel from March 2017 until January 2018, Senior Vice President and Co-General Counsel from July 2014 to March 2017, Vice President and Co-General Counsel from March 2013 to July 2014, and as Associate General Counsel and Assistant Secretary prior to that. Before joining the Company, Mr. White served in legal roles with Dollar General Corporation and Bass, Berry & Sims PLC. Mr. White received his law degree from the Vanderbilt University School of Law where he was elected to the Order of the Coif, and a B.S. in Mass Communication and Political Science from Middle Tennessee State University. He currently serves on the board of directors for Argentum.

    Ms. Warren’s biographical information is provided above under the heading “Appointment of Interim Chief Executive Officer.”

    There are no family relationships, as defined in Item 401 of Regulation S-K, between Ms. Warren, Ms. Kussow and Mr. White and any of the Company’s executive officers or directors or persons nominated or chosen to become a director or executive officer. Ms. Warren, Ms. Kussow and Mr. White have not engaged in any transaction with the Company during the last fiscal year, and do not propose to engage in any transaction, that would be reportable under Item 404(a) of Regulation S-K. There is no arrangement or understanding between Ms. Warren, Ms. Kussow and Mr. White and any other person pursuant to which they were appointed to serve as members of the Office of the CEO.

    Departure of Director

    On April 13, 2025, Frank M. Bumstead, a member of the Board, informed the Board that he will not stand for re-election at the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”). Mr. Bumstead’s decision to not stand for re-election to the Board is not due to any disagreement with the Company or the Board.

    New Director Appointment

    On April 13, 2025, the Board appointed Mark Fioravanti to the Board to fill the vacancy created by Ms. Baier’s resignation. His membership on any committee of the Board has not been determined at this time. Mr. Fioravanti will serve as a member of the Board until the 2025 Annual Meeting and until his successor is duly elected and qualified, or until his earlier resignation or removal. The Board has determined that Mr. Fioravanti qualifies as an independent director under the listing standards of the New York Stock Exchange and applicable Securities and Exchange Commission rules.

    Mr. Fioravanti is President, CEO and a member of the Board of Directors of Ryman Hospitality Properties, Inc. (RHP). In his role, Mr. Fioravanti is responsible for all facets of the company, including its portfolio of destination convention resorts and its owned and operated entertainment division, Opry Entertainment Group (OEG). A 23-year veteran of Ryman Hospitality Properties, Inc. (formerly Gaylord Entertainment), Mr. Fioravanti was appointed CEO on January 1, 2023, after serving as President and Chief Financial Officer since 2015. Prior to 2015, he served in various senior positions for RHP, including EVP and CFO, SVP and Treasurer, Division President of ResortQuest International, and SVP of Sales and Marketing. Mr. Fioravanti holds an MBA from the University of Tennessee and a BSLA from The Ohio State University. He serves on the board of the Nashville Area Chamber of Commerce, Nashville Convention and Visitors Corp., NAREIT’s Advisory Board of Governors and the Tennessee Business Leadership Council.




    Mr. Fioravanti has not engaged in any transaction with the Company during the last fiscal year, and does not propose to engage in any transaction, that would be reportable under Item 404(a) of Regulation S-K. There is no arrangement or understanding between Mr. Fioravanti and any other person pursuant to which he was appointed to serve as a member of the Board. Mr. Fioravanti will participate in the Company’s standard compensation program for non-employee directors as described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 29, 2024.

    Item 7.01 Regulation FD Disclosure.

    A copy of the Company’s press release relating to the announcement described in Item 5.02, dated April 14, 2025, is furnished as Exhibit 99.1 to this Form 8-K.

    IMPORTANT ADDITIONAL INFORMATION AND WHERE TO FIND IT

    The Company plans to file proxy materials with the U.S. Securities and Exchange Commission (the "SEC") in connection with the solicitation of proxies for the Company's 2025 Annual Meeting. Prior to the 2025 Annual Meeting, the Company will file a definitive proxy statement (the "Proxy Statement") together with a BLUE proxy card. STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE COMPANY WILL FILE WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Stockholders will be able to obtain, free of charge, copies of the Proxy Statement, any amendments or supplements thereto and any other documents (including the BLUE proxy card) when filed by the Company with the SEC at the SEC's website (http://www.sec.gov) or at the Company's website at https://brookdaleinvestors.com or by contacting Chad White, Executive Vice President, General Counsel and Secretary, by phone at (615) 221-2250, by email at [email protected] or by mail at Brookdale Senior Living Inc., 105 Westwood Place, Suite 400, Brentwood, TN 37027.

    CERTAIN INFORMATION REGARDING PARTICIPANTS

    The Company, its directors and certain of its executive officers and other employees may be deemed to be "participants" (as defined in Section 14(a) of the Securities Exchange Act of 1934, as amended) in the solicitation of proxies from stockholders in connection with the 2025 Annual Meeting. Additional information regarding the identity of these participants and their direct or indirect interests, by security holdings or otherwise, will be set forth in the Proxy Statement and other materials to be filed with the SEC in connection with the 2025 Annual Meeting. Information relating to the foregoing can also be found in the Company's definitive proxy statement for its 2024 annual meeting of stockholders, filed with the SEC on April 29, 2024. To the extent holdings of such participants in the Company's securities have changed since the amounts described in the 2024 proxy statement, such changes have been reflected in the following Statements of Beneficial Ownership on Form 3 and Statements of Change in Beneficial Ownership on Form 4 filed with the SEC with respect to the Company: Form 3, filed by Claudia Drayton on June 27, 2024; Form 3, filed by Elizabeth Mace on June 27, 2024; Form 3, filed by Ray Leisure on August 14, 2024; Form 4, filed by Jordan Asher on May 23, 2024; Form 4, filed by Claudia Drayton on August 7, 2024 and February 14, 2025; Form 4, filed by Elizabeth Mace on August 7, 2024 and February 14, 2025; Form 4, filed by Benjamin Ricci on August 21, 2024, February 14, 2025 and March 3, 2025; Form 4, filed by Jordan Asher on August 30, 2024 and February 14, 2025; Form 4, filed by Ray Leisure on October 29, 2024, February 14, 2025 and March 3, 2025; Form 4, filed by Lee Wielansky on December 6, 2024, February 14, 2025 and March 10, 2025; Form 4, filed by Frank Bumstead on February 14, 2025; Form 4, filed by Vicki Freed on February 14, 2025; Form 4, filed by Denise Wilder Warren on February 14, 2025; Form 4, filed by Lucinda Baier on February 14, 2025 and March 3, 2025; Form 4, filed by Todd Kaestner on February 14, 2025 and March 3, 2025; Form 4, filed by Chad White on February 14, 2025, March 3, 2025 and March 7, 2025; Form 4, filed by George Hicks on February 14, 2025 and March 3, 2025; Form 4, filed by Jaclyn Pritchett on February 14, 2025 and March 3, 2025; Form 4, filed by Dawn Kussow on February 14, 2025 and March 3, 2025. These filings can be found at the SEC's website at www.sec.gov. Additionally, Jessica Hazel, Vice President of Investor Relations, may be deemed a participant in the solicitation. Ms. Hazel is the beneficial owner of 44,439 shares of common stock. More detailed and updated information regarding the identity of participants in the solicitation, and their direct or indirect interests (by security holdings or otherwise), will be set forth in the Proxy Statement and other materials to be filed with the SEC. These documents can be obtained free of charge from the sources indicated above.

    Item 9.01 Financial Statements and Exhibits.

    (d) Exhibits

    99.1 Press Release dated April 14, 2025

    104 Cover Page interactive Data File (embedded within the Inline XBRL document)




    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    BROOKDALE SENIOR LIVING INC.
    Date:April 14, 2025By:/s/ Chad C. White
    Name:Chad C. White
    Title:Executive Vice President, General Counsel and Secretary



    Get the next $BKD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BKD

    DatePrice TargetRatingAnalyst
    11/10/2025$14.00Equal Weight → Overweight
    Barclays
    4/1/2025$7.00Equal Weight
    Barclays
    10/16/2024$8.00Buy
    Jefferies
    10/7/2024$7.75 → $6.00Neutral → Underperform
    BofA Securities
    6/28/2024$7.50Outperform
    Macquarie
    12/15/2023$3.95 → $6.00Underperform → Neutral
    BofA Securities
    11/17/2023$7.00 → $9.00Sector Perform → Outperform
    RBC Capital Mkts
    1/17/2023$5.00 → $4.00Buy → Hold
    Stifel
    More analyst ratings

    $BKD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Brookdale Reports November 2025 Occupancy

    NASHVILLE, Tenn., Dec. 8, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE:BKD) reported today its consolidated occupancy for November 2025. November 2025 Observations November consolidated occupancy results:Weighted average occupancy of 82.5% increased 300 basis points year-over-year and decreased 10 basis points sequentially.Historical sequential monthly occupancy change has been a 10 to 20 basis point decline.Fourth quarter-to-date occupancy of 82.6% represents an 80 basis point increase over the full third quarter of 2025.November same community occupancy results:Weighted average occupancy of 82.8% increased 250 basis points year-over-year. Weighted average occupancy decreased 20

    12/8/25 4:15:00 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    BROOKDALE ANNOUNCES CHIEF OPERATING OFFICER

    Tenured Leader Brings 40 Years of Senior Living Experience to Operations BRENTWOOD, Tenn., Nov. 18, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") is announcing that Mary Sue Patchett, current Interim Executive Vice President – Community and Field Operations, has been named Chief Operating Officer effective December 1st. Ms. Patchett brings 40 years of senior living operations experience to this role and most recently helped redesign and implement Brookdale's new regional operating structure in her interim position. "It has been ove

    11/18/25 4:15:00 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    Brookdale Announces Third Quarter 2025 Earnings Release and Conference Call Dates

    BRENTWOOD, Tenn., Oct. 22, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE:BKD) will release its third quarter 2025 financial results after the close of the market on Thursday, November 6, 2025. In conjunction with this release, the Company will hold a conference call on Friday, November 7, 2025, at 8:00 a.m. Central Time (9:00 a.m. Eastern Time) to discuss financial results. A live webcast of the conference call can be accessed at brookdaleinvestors.com. Please allow extra time before the call to download the necessary software required to listen to the internet broad

    10/22/25 4:15:00 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    $BKD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Brookdale Senior Living upgraded by Barclays with a new price target

    Barclays upgraded Brookdale Senior Living from Equal Weight to Overweight and set a new price target of $14.00

    11/10/25 9:27:25 AM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    Barclays initiated coverage on Brookdale Senior Living with a new price target

    Barclays initiated coverage of Brookdale Senior Living with a rating of Equal Weight and set a new price target of $7.00

    4/1/25 7:41:49 AM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    Jefferies initiated coverage on Brookdale Senior Living with a new price target

    Jefferies initiated coverage of Brookdale Senior Living with a rating of Buy and set a new price target of $8.00

    10/16/24 7:19:46 AM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    $BKD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Patchett Mary Sue claimed ownership of 38,837 shares (SEC Form 3)

    3 - Brookdale Senior Living Inc. (0001332349) (Issuer)

    10/8/25 4:42:53 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    Chief Executive Officer Stengle Nikolas W was granted 157,731 shares (SEC Form 4)

    4 - Brookdale Senior Living Inc. (0001332349) (Issuer)

    10/8/25 4:37:22 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    SEC Form 3 filed by new insider Stengle Nikolas W

    3 - Brookdale Senior Living Inc. (0001332349) (Issuer)

    10/8/25 4:32:13 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    $BKD
    SEC Filings

    View All

    Brookdale Senior Living Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Brookdale Senior Living Inc. (0001332349) (Filer)

    11/18/25 4:19:36 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    SEC Form 144 filed by Brookdale Senior Living Inc.

    144 - Brookdale Senior Living Inc. (0001332349) (Subject)

    11/12/25 3:15:23 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    SEC Form 10-Q filed by Brookdale Senior Living Inc.

    10-Q - Brookdale Senior Living Inc. (0001332349) (Filer)

    11/7/25 4:18:36 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    $BKD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Hicks George T bought $50,307 worth of shares (9,140 units at $5.50), increasing direct ownership by 3% to 351,883 units (SEC Form 4)

    4 - Brookdale Senior Living Inc. (0001332349) (Issuer)

    3/6/24 4:27:18 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    Bumstead Frank M bought $5,360 worth of shares (1,000 units at $5.36), increasing direct ownership by 0.20% to 500,052 units (SEC Form 4)

    4 - Brookdale Senior Living Inc. (0001332349) (Issuer)

    2/23/24 4:28:41 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    $BKD
    Leadership Updates

    Live Leadership Updates

    View All

    Ortelius Issues Final Call to Action for Brookdale Senior Living Inc. Stockholders and Encourages a Vote for Urgent Change

    Three Independent Proxy Advisors Recommend Stockholders Vote FOR Ortelius Nominees to Advance a Necessary Turnaround and End Years of Underperformance at Brookdale Vote FOR Ortelius' Nominees on the WHITE Proxy Card to Restore Accountability at Brookdale, and Immediately Begin the Process of Value Generation for Stockholders Ortelius Advisors, L.P. ("Ortelius") today issued the following open letter to fellow stockholders of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company"), encouraging stockholders who have not yet voted to consider the current Board's abysmal performance, defensive tactics, dearth of responsibility, and questionable decision-making abilities. In i

    7/7/25 7:00:00 AM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    Ortelius Director Nominees Release Joint Letter to Brookdale Stockholders

    Ortelius Nominees Believe Brookdale Offers a Tremendous Value Creation Opportunity Under a Renewed Board and New Strategic Roadmap Six Highly Qualified and Independent Nominees Will Act with Urgency, Integrity, and Transparency to Increase Value for Stockholders Brookdale Stockholders are Urged to Vote the WHITE Proxy Card FOR all Six Ortelius Nominees Ortelius Advisors, L.P. ("Ortelius") today announced that the six highly qualified individuals nominated by Ortelius for election to the Board of Directors (the "Board") of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") at the upcoming 2025 Annual Meeting of Stockholders released a joint letter to Brookdale stock

    7/3/25 8:00:00 AM ET
    $BKD
    $GMRE
    $NTST
    Hospital/Nursing Management
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Glass Lewis Recommends Stockholders Vote for Change at Brookdale Senior Living Inc.

    Third Independent Proxy Advisor Confirms the Persuasive Case to Bolster Key Competencies on the Brookdale Board and Recommends Stockholders Vote FOR Ortelius Nominees to Advance a Necessary Turnaround Glass Lewis Identifies Governance Challenges at Brookdale Including the Persistent Lack of Accountability for Legacy Directors who have Overseen Poor Performance Furthering the Need for Board Renewal Ortelius Urges Brookdale Stockholders to Vote FOR all Six of Ortelius' Nominees on the WHITE Proxy Card Ortelius Advisors, L.P. ("Ortelius") today announced that a third leading independent proxy advisory firm, Glass, Lewis & Co. ("Glass Lewis"), has recommended that stockholders vote FOR th

    7/1/25 4:30:00 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    $BKD
    Financials

    Live finance-specific insights

    View All

    Brookdale Announces Third Quarter 2025 Earnings Release and Conference Call Dates

    BRENTWOOD, Tenn., Oct. 22, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE:BKD) will release its third quarter 2025 financial results after the close of the market on Thursday, November 6, 2025. In conjunction with this release, the Company will hold a conference call on Friday, November 7, 2025, at 8:00 a.m. Central Time (9:00 a.m. Eastern Time) to discuss financial results. A live webcast of the conference call can be accessed at brookdaleinvestors.com. Please allow extra time before the call to download the necessary software required to listen to the internet broad

    10/22/25 4:15:00 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    Brookdale Announces Second Quarter 2025 Earnings Release and Conference Call Dates

    NASHVILLE, Tenn., July 23, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE:BKD) plans to release its second quarter 2025 financial results after the market closes on Wednesday, August 6, 2025. The Company also plans to discuss the results on a conference call scheduled for Thursday, August 7, 2025, at 9:00 a.m. (ET). BROOKDALE SENIOR LIVING - EARNINGS CALLDate: Thursday, August 7, 2025Time: 9:00 a.m. (ET) / 8:00 a.m. (CT) Call Within US: +1 (800) 715-9871Call Outside US: +1 (646) 307-1963Conference ID: 1482282 A webcast of the conference call will be available to the p

    7/23/25 6:45:00 AM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    Ortelius Reaffirms Strategy to Unlock Sustainable Long-Term Value for Brookdale Senior Living Inc. Stockholders

    The Brookdale Board's Ongoing Missteps, Shortcomings, and Strategic Failures are Palpable, and Jeopardize the Company's Viability Contrary to the Current Board's Assertions, Ortelius' Strategy is Materially Different from the Company's Current Plans Ortelius' Nominees Would Restore Accountability at Brookdale, and Immediately Begin the Process of Substantial Value Generation for Stockholders Ortelius Advisors, L.P. ("Ortelius") today issued the following open letter to fellow stockholders of Brookdale Senior Living Inc. (NYSE:BKD)("Brookdale" or the "Company"), which further outlines that the judgement, execution, and decision-making abilities of Brookdale's current Board of Directors

    6/16/25 8:00:00 AM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    $BKD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Brookdale Senior Living Inc.

    SC 13G/A - Brookdale Senior Living Inc. (0001332349) (Subject)

    11/14/24 4:43:24 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Brookdale Senior Living Inc.

    SC 13G/A - Brookdale Senior Living Inc. (0001332349) (Subject)

    11/14/24 4:17:59 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G/A filed by Brookdale Senior Living Inc. (Amendment)

    SC 13G/A - Brookdale Senior Living Inc. (0001332349) (Subject)

    2/14/24 4:46:08 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care